6/30/05 - Annual Meeting of Stockholders of Calypte Biomedical Corporation will be held at the Four Points
Sheraton Hotel located at 5115 Hopyard Road, Pleasanton, California, 94588, on Thursday, June 30, 2005, at 10:00 a.m. local time, for the following purposes:
1. To elect five directors of the Company to hold office until the next Annual Meeting of Stockholders or until their successors are elected.
2. To vote on a proposal to approve the issuance of shares of common stock in excess of 19.99% of the outstanding common stock and price adjustments in connection with our April 2005 issuance of Notes and
Warrants;
3. To vote on a proposal to approve the issuance of additional shares of common stock and warrant shares and adjustment of the warrant exercise price in connection with amended securities granted to 3
the investors in our May and July 2004 placements;
4. To vote on a proposal to adopt the Company's 2005 Director Incentive Plan (Appendix A hereto) and to authorize 18,000,000 shares of the Company's Common Stock for issuance thereunder;
5. To vote on a proposal to amend the Company's 2004 Incentive Plan(Appendix B hereto) to increase by 17,000,0000 shares the number of shares of the Company's Common Stock authorized for issuance
thereunder; to permit awards to employees, consultants and others who provide services to affiliates of the Company thereunder; and to increase to 20,000,000 shares the number of shares of Common Stock available for delivery as restricted stock and restricted stock
units thereunder;
6. To ratify the appointment by the Audit Committee and the Board of Directors of Odenberg Ullakko Muranishi & Co. LLP as the independent registered public accounting firm to audit the Company's 6 financial statements for the fiscal year ending December 31, 2005.
Gruß
C.O |
Thread abonnieren
